Search All Resources
Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians (NIH)
Type: Website
Audience: Clinical
Program: Hepatitis C
Keywords: #injection drug use #injection drugs
Injection drug use-associated bacterial and viral infections are increasing. Expanding access to harm reduction services, such as safe injection education, are effective prevention strategies. However, these strategies have had limited uptake. New tools are needed to improve provider capacity to ...
Date added: 11/4/22
New Data: Buprenorphine and Benzodiazepine Overdose Risk | November 2, 2022
Type: Past Presentation
Program: Hepatitis C
Keywords: #benzo #benzodiazepine #bup #buprenorphine #clonidine #literature #od #overdose #suboxone
In this presentation, Dr. Jasen Christensen, DO, discusses how the addition of buprenorphine changes overdose risk, explains the affect of buprenorphine on risk for benzodiazepine overdose and describes the use of Clonidine in MOUD treatment.
Date added: 11/2/22
Language of Addiction | October 19, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #language #mat #MOUD #non-stigmatizing language #OUD #Recovery #substance use disorders #SUD
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the language recommended by the Office of National Drug Control Policy.
Date added: 10/19/22
Pre-Exposure Prophylaxis (PrEP) for HIV Prevention | October 26, 2022
Type: Past Presentation Training
Audience: Clinical
Program: Hepatitis C Ending the Epidemics in Indian Country ECHO Program
Keywords: #hiv #pre-exposure prophylaxis #prep
In this presentation, Dr. Jorge Mera, Indian Country ECHO Medical Director and Director of Infectious Diseases at Cherokee Nation, discusses HIV PrEP, the evidence on effectiveness, monitoring, and best practices, including remote provision of PrEP care services.
Date added: 10/11/22
Peer Support Specialists: A New Perspective in Non-traditional Settings | September 28, 2022
Type: Past Presentation
Audience: Clinical Community
Program: Hepatitis C
Keywords: #hcv #peer support #Peers #Recovery #SUD
In this presentation, O’Nesha Cochran, a certified peer recovery mentor, shares her story and provides an overview of peer recovery support, how people interested in peer recovery can become certified, and potential barriers to peer support.
Date added: 09/28/22
Choosing to Start HCV Elimination | August 24, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #elimination #hcv #hepatitis #hepc #pharmacist #pharmacy #pharmacy-based clinic #viral
In this presentation, Dr. Whitney Dickson, PharmD, presents on her efforts and lessons learned in starting an HCV Elimination Program at Cass Lake IHS. Dr. Dickson discusses understanding the need for HCV services, summarizes the steps taken to start an ...
Date added: 08/22/22
Hepatitis B and D Coinfection | August 17, 2022
Type: Past Presentation
Program: Hepatitis C
Keywords: #hbv #HDV #hepatitis #hepatitis b #hepatitis d
In this presentation, Dr. Paulina Deming, ECHO faculty member and Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses background data on global hepatitis D virus (HDV) prevalence, patients who may be at risk for HDV, ...
Date added: 08/17/22
Buprenorphine: Prescribing and Review of Literature (Part 2) | August 3, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #benzo #benzodiazepine #bup #buprenorphine #hcv #induction #naloxone #opioid use disorder #OUD
In this presentation, Dr. Jasen Christensen presents on buprenorphine and other options for managing opioid use disorder. Dr. Christensen reviews buprenorphine induction, literature informing current prescribing best practices, and discusses data supporting buprenorphine for chronic pain.
Date added: 08/3/22
Hepatitis B Virus | July 27 2022
In this presentation Dr. Karla Thornton discusses Hepatitis B Virus and serology interpretation. She describes the modes of transmission for HBV, how to identify appropriate baseline serologies for HBV and how to correctly interpret serologic tests for HBV.
Date added: 07/27/22
Common Drug-Drug Interactions with HCV DAAs | June 22, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #drug interactions #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this presentation, Bradley Moran, PharmD, shares a valuable overview of common medication interactions with hepatitis C medications.
Date added: 06/22/22